ASBP ASBP
Company Profile ↓Company Overview
ASBP (ASBP) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -50.27% |
| 6 Months: | +345.40% |
| 3 Months: | +3,530.00% |
| 1 Month: | +29.41% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)56.59 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 69.2% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 28.35K |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 884 | 5.75K |
| Operating Income | - | - | - | - | - | - | - | - | - | - | -215.26K | - | -15.56M | - | -1.15M | -1.65M |
| Net Income | -2.38K | -15.31K | -87.83K | 120.69K | 1.08M | 2.87M | 1.81M | -69.26K | -230.97K | -96.92K | -216.27K | -765.71K | -15.94M | -1.98M | -1.85M | -3.22M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | -0.01 | - | -504.88 | - | -0.04 | -20.57 |
| R&D Expense | - | - | - | - | - | - | - | - | 10.50K | 10.50K | 7.00K | - | 263.09K | 352.89K | 207.90K | 296.72K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | 6.20K |
| Gross Profit | - | - | - | - | -116 |
| Operating Income | - | - | - | -1.21M | -19.35M |
| Net Income | -25.48K | 3.34M | 4.46M | -1.31M | -24.48M |
| Diluted EPS | - | - | - | -1.90 | -16.38 |
| R&D Expense | - | - | - | 144.36K | 923.91K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Feb 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 293.22K | 300.18M | 19.98M | 147.99K | 1.31M |
| Total Equity | 0 | -475 | -9.94M | -487.86K | -1.54M | -6.38M |
| Total Liabilities | - | 293.70K | 11.12M | 403.33K | 1.69M | 7.69M |
| Current Liabilities | - | 293.70K | 303.32K | 403.33K | 1.69M | 7.59M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -238.60K | -142.91K | 11.14K | -265.19K | -4.92M |
| Investing Cash Flow | - | -4.90M | 0 | 0 | - |
| Financing Cash Flow | 238.60K | 4.85M | 0 | 257.64K | 5.92M |
| Capital Expenditure | - | -4.90M | -75.90K | - | - |
| Free Cash Flow | - | -5.04M | 11.14K | -265.19K | -4.92M |
| Net Change in Cash | - | -185.46K | 11.14K | -7.54K | 1.00M |
| Share Buybacks | - | - | 284.92M | 13.78M | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | -1.9% |
| Operating Margin % | - | - | - | - | -312,016.9% |
| Net Margin % | - | - | - | - | -394,725.1% |
| ROE % | 5,363.2% | -33.6% | -915.0% | 85.1% | 383.9% |
| ROCE % | - | - | - | 78.6% | 308.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ASBP
ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNVXk4TS03VnlWQ2tHdnZfNmFHZWtKN1g4QVl4VFBaZXp2VWV6NWFieXM0NThNNGdhTVoxVVRvYUYtaVZQRjZPOWdZcHh3cHFzSFVIUmFGSTdJVzY5WC0wakhqUmJFWEJWaWZtTjBDQWZjZ3JhbDdFT09UcWdycHJ5aEl2RldJVFpVdUh3NU…
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxNWGNETHJKN3I4WGtCNkwwX3JndzdZUi1fVmxOc3hoU0pUXzJsT2ktSjk4a1RNTmFlLVBzeHhaejFhcFFTWFpYMlFqejZXbWRHcEtIczkxb3VLSjRCWHUya0dNcmpydkp3M2pOTEJqN0w5VjdlQWJlNmplcFcwZWZPXzl3Slo1bkVLYmJRMX…
Aspire Biopharma puts 50 mg caffeine stick packs on Amazon - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQa1VCaFpSS1VUUjJkUFpvNEQxa2VvVElxa1UtTUZqaDV5V3poRmZ4VExlNGRsQnc4cWV4REtQd29CZ1hMckhkUHo4dEVpVmtRNEJTV2lNaXpKT09rUnNjVHdfV24zaXVnQ1ZQRFpUX1c4UEdoa0pfLUY3R3JrRkUxMkhONTFwMVdjdmlHeV…
Aspire Biopharma Stock Is Sliding Today: What's Going On? - Aspire Biopharma Holdings (NASDAQ:ASBP) - Benzinga
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPak5NczVJenlrMmtkTFFlb20xeWo1VzA1Tm1FYXZmTE9waFVHUkViVnZwX0trMjY5SWNWM3pON29mSkFVSlRhWHJlWE1ncFgwb3o3UkZQSGdxX0VVYUVHaWFRVUJYSERXR3V5Zl83QWVpX3Z1RnlMYUtEREt4X1pCcGU5bUxxTVBva0hQYz…
ASBP|Aspire Biopharma Holdings Inc|Price:7.190|Chg%:-0.040 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5RS241YmRtUGlrSHBTejVRWjRxMFEwLWdSYi14UFVkRWs5U3RvQ0loUGEtekZoWWl1UUZLMmd5ZktsOVpnNUR5VTE0R08wYzdVNzVhbjc3M0tVNXFPRDRrU2ItYUdScmlubkZHR3RR?oc=5" target="_blank">ASBP|Aspire Biophar…
ASBP Stock Draws Trader Focus As Volatility Spikes - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPcFp0VGJWNjRDSWtiSlhLb3M1LWxxQVlCelItR1dESXE0TE9ZMEszLU5oSGpBWFJaQkJpVnY0eXliSVVXa0ZrZFA5OU1yNkJSMlFHN0xqVlJ0R3JFd2tDMmRmVlVWdV83QUxBS2RIQUZDSTBMUnlWT21lS3EyOWc0SFpSZTN0ZFRZaEE?oc…
ASBP — Frequently Asked Questions
What is the current share price of ASBP?
As of 2026-08-05 17:25 PDT, ASBP trades at $7.26 on NASDAQ/NYSE. Its 52-week range is $0.16 to $23.60.
What is the P/E ratio of ASBP?
ASBP trades at a trailing price-to-earnings (P/E) ratio of -0.44.
Is ASBP a good stock to buy?
This page provides a data-driven analysis of ASBP, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.